Results

eNauka >  Rezultati >  Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts
Naziv: Osimertinib is selective against NSCLC cells and modulates the multidrug-resistant phenotype in patient-derived cell cultures and co-cultures of NSCLC cells and fibroblasts
Autori: Jovanović Stojanov, Sofija  ; Podolski-Renić, Ana  ; Dinić, Jelena  ; Dragoj, Miodrag  ; Jovanović, Mirna  ; Stepanović, Ana  ; Lupšić, Ema  ; Bajović, Radovan; Glumac, Sofija  ; Marić, Dragana  ;
Godina: 2023
Publikacija: ESMO Open (Abstract Book of the ESMO Targeted Anticancer Therapies Congress (TAT); 2023 Mar 6-8; Paris, France
ISSN: 2059-7029 ESMO Open Pretraži identifikator
Izdavač: [London] : Elsevier
Tip rezultata: Konferencijski rad
Kolacija: vol. 8 br. 1 Suppl 2 str. 100927
DOI: 10.1016/j.esmoop.2023.100927
URI: https://enauka.gov.rs/handle/123456789/759108
http://radar.ibiss.bg.ac.rs/handle/123456789/5712
https://radar.ibiss.bg.ac.rs/handle/123456789/5712
URL: https://www.sciencedirect.com/science/article/pii/S2059702923001473?via%3Dihub
Projekat: TargetedResponse - Functional diagnostics in non-small cell lung carcinoma: A new concept for the improvement of personalized therapy in Serbian patients
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.